Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Sweden
/
Healthcare
Create a narrative
Medicover Community
OM:MCOV B Community
3
Narratives
written by author
0
Comments
on narratives written by author
9
Fair Values set
on narratives written by author
Community Investing Ideas
Medicover
Popular
Undervalued
Overvalued
Medicover
AN
AnalystLowTarget
Consensus Narrative from 7 Analysts
Rising European Labor Costs And Regulatory Burdens Will Squeeze Margins
Key Takeaways Sustained cost pressures, workforce shortages, and integration issues threaten Medicover's margins and ability to achieve expected synergies from acquisitions. Heightened regulatory, technological, and macroeconomic risks may limit efficiency gains and expose Medicover to market share loss and volatile revenue growth.
View narrative
SEK 219.70
FV
22.7% overvalued
intrinsic discount
8.44%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Medicover
AN
AnalystHighTarget
Consensus Narrative from 7 Analysts
Digitalization And Diagnostics Will Unlock Secular Private Healthcare Growth
Key Takeaways Margin expansion and earnings growth are outpacing expectations, driven by fast integration of acquisitions, efficiency gains, and digital transformation. Medicover is positioned for continued growth due to rising healthcare demand in key markets and its scalable, consolidation-focused strategy.
View narrative
SEK 326.23
FV
17.4% undervalued
intrinsic discount
14.76%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Medicover
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
Demographic Shifts And Digitalization Will Unlock Healthcare Opportunity
Key Takeaways Demographic trends, market shifts to private healthcare, and focus on diagnostics drive recurring revenue and longer-term patient retention for Medicover. Acquisition integration, digitalization, and service diversification improve margins, operational efficiency, and earnings scalability across expanding hospital and diagnostics networks.
View narrative
SEK 268.90
FV
0.2% overvalued
intrinsic discount
11.63%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
4 days ago
author updated this narrative
Your Valuation for
MCOV B
MCOV B
Medicover
Your Fair Value
SEK
Current Price
SEK 269.50
20.6% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
4b
2015
2018
2021
2024
2025
2027
2030
Revenue €3.7b
Earnings €71.4m
Advanced
Set Fair Value